UHN’s Medly Now Available Through VITALL

Why It Matters

Medly provides a scalable, evidence‑based tool that cuts costly heart‑failure admissions, freeing beds and improving outcomes across Canada’s strained health system.

Key Takeaways

• 50% drop in heart‑failure hospitalizations with Medly.
• 35% fewer in‑person appointments for enrolled patients.
• AI‑driven app adjusts medication daily under clinician oversight.
• Service targets high‑risk Class III/IV HF patients, saving $27k annually.
• VITALL provides turnkey rollout, enabling rapid regional scaling.

Pulse Analysis

Heart failure remains one of Canada’s most expensive chronic conditions, driving roughly 9.6‑day average hospital stays and frequent readmissions. Digital therapeutics have emerged as a viable strategy to shift care from hospitals to patients’ homes, and Medly is among the few solutions with rigorous clinical validation. Over 3,000 users across UHN, partner institutions, and Indigenous health authorities have generated more than 30 peer‑reviewed studies, consistently reporting a 50 % cut in HF‑related admissions and a 35 % reduction in routine clinic visits. These outcomes illustrate how algorithm‑guided self‑management can accelerate guideline‑directed medical therapy while curbing costly decompensation events.

VITALL’s commercial rollout packages Medly within a secure, SOC II‑certified FHIR architecture that aggregates smartphone data, device inputs, and at‑home tests into a real‑time clinician dashboard. The AI‑enhanced engine proposes daily medication tweaks, flags deteriorations, and allows nurse‑led teams to intervene before patients require emergency care. By automating routine monitoring, clinicians experience predictable workflows and reclaimed capacity for high‑acuity cases. Patients benefit from continuous feedback, reduced anxiety, and greater confidence in managing their condition, while remote‑capable nurses can extend services to rural and Indigenous communities without sacrificing oversight.

The turnkey nature of VITALL’s offering—covering implementation, training, and ongoing support—positions it for rapid adoption across provincial health networks. For the average Class III/IV heart‑failure patient, avoiding a single hospitalization can save upwards of $27,000 annually, translating into significant system‑wide cost avoidance when scaled to the 20 % high‑risk cohort. Moreover, freeing beds and shortening wait times directly addresses the chronic capacity strain in Canadian emergency departments. As policymakers prioritize value‑based care, Medly’s proven efficacy and scalable model could become a benchmark for future digital therapeutic contracts nationwide.